Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Implications and problems of the Sudden Cardiac Death in Heart Failure Trial.

Shimizu W, Satomi K.

Future Cardiol. 2005 Sep;1(5):599-603. doi: 10.2217/14796678.1.5.599.

PMID:
19804098
[PubMed]
2.

Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2005;5(14):1-74. Epub 2005 Sep 1.

PMID:
23074465
[PubMed]
Free PMC Article
3.

Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial.

Packer DL, Prutkin JM, Hellkamp AS, Mitchell LB, Bernstein RC, Wood F, Boehmer JP, Carlson MD, Frantz RP, McNulty SE, Rogers JG, Anderson J, Johnson GW, Walsh MN, Poole JE, Mark DB, Lee KL, Bardy GH.

Circulation. 2009 Dec 1;120(22):2170-6. doi: 10.1161/CIRCULATIONAHA.109.853689. Epub 2009 Nov 16. Erratum in: Circulation. 2010 Feb 16;121(6):e39.

PMID:
19917887
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Where patients with mild to moderate heart failure die: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

Olshansky B, Wood F, Hellkamp AS, Poole JE, Anderson J, Johnson GW, Boineau R, Domanski MJ, Mark DB, Lee KL, Bardy GH; SCD-HeFT Investigators.

Am Heart J. 2007 Jun;153(6):1089-94.

PMID:
17540216
[PubMed - indexed for MEDLINE]
5.

Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2005;5(13):1-60. Epub 2005 Sep 1.

PMID:
23074464
[PubMed]
Free PMC Article
6.

New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.

Klein H, Auricchio A, Reek S, Geller C.

Am J Cardiol. 1999 Mar 11;83(5B):91D-97D. Review.

PMID:
10089848
[PubMed - indexed for MEDLINE]
7.

Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).

Fishbein DP, Hellkamp AS, Mark DB, Walsh MN, Poole JE, Anderson J, Johnson G, Lee KL, Bardy GH; SCD-HeFT Investigators.

J Am Coll Cardiol. 2014 Jun 17;63(23):2560-8. doi: 10.1016/j.jacc.2014.02.602. Epub 2014 Apr 9.

PMID:
24727258
[PubMed - in process]
8.

Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial.

Russo AM, Poole JE, Mark DB, Anderson J, Hellkamp AS, Lee KL, Johnson GW, Domanski M, Bardy GH.

J Cardiovasc Electrophysiol. 2008 Jul;19(7):720-4. doi: 10.1111/j.1540-8167.2008.01129.x. Epub 2008 Mar 26.

PMID:
18373605
[PubMed - indexed for MEDLINE]
9.

Role of antiarrhythmic therapy in patients at risk for sudden cardiac death: an evidence-based review.

Hilleman DE, Bauman AL.

Pharmacotherapy. 2001 May;21(5):556-75. Review.

PMID:
11349745
[PubMed - indexed for MEDLINE]
10.

Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

Mark DB, Nelson CL, Anstrom KJ, Al-Khatib SM, Tsiatis AA, Cowper PA, Clapp-Channing NE, Davidson-Ray L, Poole JE, Johnson G, Anderson J, Lee KL, Bardy GH; SCD-HeFT Investigators.

Circulation. 2006 Jul 11;114(2):135-42. Epub 2006 Jul 3.

PMID:
16818817
[PubMed - indexed for MEDLINE]
Free Article
11.

Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

Freudenberger RS, Hellkamp AS, Halperin JL, Poole J, Anderson J, Johnson G, Mark DB, Lee KL, Bardy GH; SCD-HeFT Investigators.

Circulation. 2007 May 22;115(20):2637-41. Epub 2007 May 7.

PMID:
17485579
[PubMed - indexed for MEDLINE]
Free Article
12.

Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.

Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H, Kutalek SP, Sharma A; Dual Chamber and VVI Implantable Defibrillator Trial Investigators.

JAMA. 2002 Dec 25;288(24):3115-23.

PMID:
12495391
[PubMed - indexed for MEDLINE]
13.

The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.

Wilkoff BL; Dual Chamber and VVI Implantable Defibrillator trial investigators.

Card Electrophysiol Rev. 2003 Dec;7(4):468-72.

PMID:
15071277
[PubMed - indexed for MEDLINE]
14.

Cost-benefit analysis of primary prevention of sudden cardiac death with an implantable cardioverter defibrillator versus amiodarone in Canada.

Deniz HB, Ward A, Jaime Caro J, Alvarez P, Sadri H.

Curr Med Res Opin. 2009 Mar;25(3):617-26. doi: 10.1185/03007990802695037 .

PMID:
19232036
[PubMed - indexed for MEDLINE]
15.

Differences in outcomes between patients treated with single- versus dual-chamber implantable cardioverter defibrillators: a substudy of the Multicenter Automatic Defibrillator Implantation Trial II.

Berenbom LD, Weiford BC, Vacek JL, Emert MP, Hall WJ, Andrews ML, McNitt S, Zareba W, Moss AJ.

Ann Noninvasive Electrocardiol. 2005 Oct;10(4):429-35.

PMID:
16255753
[PubMed - indexed for MEDLINE]
16.

[Antiarrhythmic therapy in patients with heart failure].

Faber TS, Zehender M.

Ther Umsch. 2000 May;57(5):324-32. Review. German.

PMID:
10859993
[PubMed - indexed for MEDLINE]
17.

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators.

N Engl J Med. 2005 Jan 20;352(3):225-37. Erratum in: N Engl J Med. 2005 May 19;352(20):2146.

PMID:
15659722
[PubMed - indexed for MEDLINE]
Free Article
18.

How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with "SCD-HeFT criteria?".

Zecchin M, Merlo M, Pivetta A, Barbati G, Lutman C, Gregori D, Serdoz LV, Bardari S, Magnani S, Di Lenarda A, Proclemer A, Sinagra G.

Am J Cardiol. 2012 Mar 1;109(5):729-35. doi: 10.1016/j.amjcard.2011.10.033. Epub 2011 Dec 15.

PMID:
22176998
[PubMed - indexed for MEDLINE]
19.

Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society.

Silka MJ, Kron J, Dunnigan A, Dick M 2nd.

Circulation. 1993 Mar;87(3):800-7.

PMID:
8443901
[PubMed - indexed for MEDLINE]
20.

Primary prevention of sudden cardiac death by implantable cardioverter-defibrillator therapy in Chinese patients with heart failure: a single-center experience.

Chen TB, Cheng KA, Gao P, Cheng ZW, Fan JB, Jiang XC, Fang Q.

Chin Med J (Engl). 2010 Apr 5;123(7):848-51.

PMID:
20497676
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk